Can a Heartbeat-Based guide improve fluid balance in brain surgery?
NCT ID NCT07787455
First seen Aug 26, 2026 · Last updated Aug 27, 2026 · Updated 1 time
Summary
This trial tests whether using pulse pressure variability (PPV) to guide fluid therapy during brain surgery (craniotomy) can reduce the amount of IV fluids given compared to the traditional central venous pressure (CVP) method. The study will enroll 50 adults aged 18-65 who are having craniotomy operations. The goal is to see if PPV-guided fluid management leads to more precise fluid administration, potentially improving patient outcomes.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Goal-directed fluid therapy using pulse pressure variability (PPV) compared with central venous pressure (CVP) monitoring
- What this could lead to
- If PPV-guided fluid therapy proves better, it could lead to more precise fluid management during brain surgery, potentially reducing complications and improving recovery.
- What could go wrong
- This is a small, early-stage trial (50 patients), so results may not apply broadly. PPV may not be reliable in all patients, and the study may not show a clear advantage over standard CVP monitoring.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
50 people
The number who actually took part.
- Started
-
Jan 2026
- Finished
-
Aug 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
PT WAS RANDOMLY ALLOACTED TO 2 GROUPS GROUP A : CVP BETWEEN 8-10 CMH2O GROUP B : PPV LESS THAN 13 %
- Ages
-
18 to 65 years
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * ASA I,II AGE 18-65 Exclusion Criteria: CHRONIC CARDIC ARRHYTHMIA FLASE HIGH CVP ALTERED MYOCARDIAL FUNCTION PERIPHRAL VASCULAR DISEASE SEVER RESPRITORY DISEASE PEREGANACY PATIENT REFUSAL EXCESSIVE BLOOD LOSS OPERATIONS \-
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Volume of fluid are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ain Shams University
Cairo, Egypt